ARTERIAL VASCULAR ENGINEERING INC
SC 13G/A, 1997-02-14
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: ARTERIAL VASCULAR ENGINEERING INC, 10-Q, 1997-02-14
Next: EXCITE INC, SC 13D, 1997-02-14



                                            ----------------------------------
                  UNITED STATES                       OMB APPROVAL
                                            ----------------------------------
                                            ----------------------------------
        SECURITIES AND EXCHANGE COMMISSION  OMB Number:    3235-0145
              WASHINGTON, D.C. 20549        Expires:  December 31, 1997
                                            Estimated average burden
                                            hours per response         14.90
                                            ----------------------------------

                                  SCHEDULE 13G

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (Amendment No. 1)*

                       Arterial Vascular Engineering, Inc.
                    ------------------------------------------
                                (Name of Issuer)

                                  Common Stock
                    ------------------------------------------
                         (Title of Class of Securities)

                                   043013-10-1
                    ------------------------------------------
                                 (CUSIP Number)

Check the following  box if a fee is being paid with this  statement [ ]. (A fee
is not required only if the filing person:  (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class securities
described in Item 1; and (2) has filed no amendment subsequent thereto reporting
beneficial ownership of five percent or less of such class.) (See Rule 13d-7).

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any  subsequent  amendment  containing  information  which  would  alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                                       1.
<PAGE>
<TABLE>
<CAPTION>
<S>                                                          <C>                          <C>

- -----------------------------------------------------                                     -----------------------------------------
CUSIP No.    043013-10-1                                     13G                                 Page 2 of 4 Pages
         -------------------------                                                                                
- -----------------------------------------------------                                     -----------------------------------------

- ------------- ---------------------------------------------------------------------------------------------------------------------
1             NAME OF REPORTING PERSONS                          
              S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
                                                  John D. Miller;  Social Security No.   ###-##-####
- ------------- ---------------------------------------------------------------------------------------------------------------------
2             CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                  (a) [  ]
                                                  Not Applicable                                 (b) [  ]
- ------------- ---------------------------------------------------------------------------------------------------------------------
3             SEC USE ONLY                                       

- ------------- ---------------------------------------------------------------------------------------------------------------------
4             CITIZENSHIP OR PLACE OF ORGANIZATION               
                                                  United States
- ---------------------------- ------- ----------------------------------------------------------------------------------------------
                               5     SOLE VOTING POWER                                        
                                              1,933,339*
         NUMBER OF
                             ------- ----------------------------------------------------------------------------------------------
 SHARES BENEFICIALLY OWNED     6     SHARED VOTING POWER                                      
            BY                                0
                             ------- ----------------------------------------------------------------------------------------------
EACH REPORTING PERSON WITH     7     SOLE DISPOSITIVE POWER                                   
                                              1,933,339*
                             ------- ----------------------------------------------------------------------------------------------
                               8     SHARED DISPOSITIVE POWER                                 
                                              0
- ---------------------------- ------- ----------------------------------------------------------------------------------------------
9              AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                                                  1,933,339*
- ------------- ---------------------------------------------------------------------------------------------------------------------
10            CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
                                                  [X]
- ------------- ---------------------------------------------------------------------------------------------------------------------
11            PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

                                                  6.24%
- ------------- ---------------------------------------------------------------------------------------------------------------------
12            TYPE OF REPORTING PERSON*

                                                  IN
- ------------- ---------------------------------------------------------------------------------------------------------------------
<FN>
                                
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!
</FN>
</TABLE>
                                       2.

<PAGE>

ITEM 1.

      (a)Name of Issuer:            Arterial Vascular Engineering, Inc.

      (b)Address of Issuer's Principal Executive Offices:  3576 Unocal Place
                                                           Santa Rosa, CA 95403
ITEM 2.

       (a)        Name of Person Filing:    John D. Miller

       (b)        Address of Principal Business Office:    3576 Unocal Place
                                                           Santa Rosa, CA  95403
       (c)        Citizenship:              United States

       (d)        Title of Class of Securities:               Common Stock

       (e)        CUSIP Number:             043013-10-1

ITEM 3.  Not Applicable

ITEM 4.  Ownership

      (a)Amount Beneficially Owned:         1,933,339*

      (b)Percent of Class:          6.24%

      (c)Number of shares as to which such person has:

                  (i)   sole power to vote or to direct the vote:    1,933,339*

                  (ii)  shared power to vote or to direct the vote: 0

                  (iii) sole power to dispose or to direct the disposition of: 
                                                                     1,933,339*

                  (iv)  shared power to dispose or to direct the disposition of:
                                                                    0

*Includes  445,268 shares held by a trust for the benefit of the children of Dr.
Simon H.  Stertzer,  of which John D. Miller is trustee  and as to which  shares
John D.  Miller  disclaims  beneficial  ownership,  and 10,000  shares held by a
foundation  of which John D. Miller and Doreen D. Miller (Mr.  Miller's  spouse)
are  co-trustees  and as to which  shares  John D. Miller  disclaims  beneficial
ownership.  Excludes  400,277  shares held by family  trusts for which Doreen D.
Miller (Mr.  Miller's spouse) and J.P. Morgan  California are co-trustees and as
to which shares Mr. Miller disclaims beneficial ownership.

                                       3.
<PAGE>

ITEM 5.  Ownership of Five Percent or Less of a Class
                  Not Applicable

ITEM 6.  Ownership of More than Five Percent on Behalf of Another Person
                  Not Applicable

ITEM 7.  Identification and Classification of the Subsidiary Which
         Acquired the Security Being Reported on by the Parent Holding Company
                  Not Applicable


ITEM 8.  Identification and Classification of Members of the Group
                  Not Applicable


ITEM 9.  Notice of Dissolution of Group
                  Not Applicable


ITEM 10. Certification
                  Not Applicable



                                    SIGNATURE

After  reasonable  inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

                                      February 14, 1997
                                      -------------------------
                                      Date

                                      /s/ John D. Miller
                                      -------------------------
                                      John D. Miller

                                       4.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission